Midwifery Department, Rasht Branch, Islamic Azad University, Rasht, Iran.
Midwifery Department, Shahid Beheshti University of Medical Sciences (SBMU), Vali-Asr Ave, Niayesh Cross Road, Niayesh Complex, Tehran, 1985717443, Iran.
BMC Womens Health. 2024 Jan 24;24(1):66. doi: 10.1186/s12905-023-02836-9.
Effective interventions to improve sexual dysfunction in breast cancer survivors need screening of these dysfunctions with a suitable instrument. The aim of present study was translation and identifying psychometric properties of Female Sexual Function Index - Adapted for Breast Cancer (FSFI-BC) which has been specifically developed for breast cancer survivors.
This methodological study was performed between February 2017 and October 2018. 200 breast cancer survivors in stage 1 or 2 who were selected through convenience sampling method, completed the questionnaire. Reliability was assessed by Cronbach's alfa and test re-test analysis and construct validity was performed through confirmatory (CFA) and exploratory factor analysis( EFA).
Six factors were extracted in exploratory factor analysis (EFA). These factors explained 74.6% of the total variance in in NSA group and 0.821 in SA group. Reliability evaluation indicated high internal consistency and good test re-test reliability. Cronbach's alpha coefficient in all areas of the tool was above 0.7 (the lowest and the highest measures were 0.885 and 0.945, respectively), which is a good indicator for reliability of an instrument. Confirmatory factor analysis showed an acceptable fitness for seven factors of FSFI-BC questionnaire (Normed Fit Index or NFI = 0.9 for both groups, Comparative of Fit Index or CFI = 0.93 and 0.92, χ 2/df = 1.68 and 1.71 for SA(Sexually Active) and NSA(No Sexually Active) individuals, respectively) .
Study findings suggest that Persian version of FSFI-BC is a suitable instrument for sexual dysfunction screening in breast cancer survivors.
为改善乳腺癌幸存者的性功能障碍,需要使用合适的工具对这些功能障碍进行筛查。本研究旨在翻译并确定专为乳腺癌幸存者开发的女性性功能指数-适应乳腺癌(FSFI-BC)的心理测量特性。
这是一项在 2017 年 2 月至 2018 年 10 月之间进行的方法学研究。通过便利抽样法选择了 200 名处于 1 期或 2 期的乳腺癌幸存者,他们完成了问卷。通过 Cronbach's alfa 进行信度评估和测试重测分析,通过验证性(CFA)和探索性因子分析(EFA)进行结构有效性评估。
在探索性因子分析(EFA)中提取了 6 个因子。这些因素解释了 NSA 组总方差的 74.6%,SA 组的 0.821。可靠性评估表明内部一致性高,重测信度好。该工具所有领域的 Cronbach's alpha 系数均高于 0.7(最低和最高测量值分别为 0.885 和 0.945),这是仪器可靠性的良好指标。验证性因子分析表明,FSFI-BC 问卷的七个因子具有可接受的拟合度(两组的归一拟合指数或 NFI 均为 0.9,比较拟合指数或 CFI 分别为 0.93 和 0.92,χ 2/df 分别为 1.68 和 1.71,适用于有性行为(SA)和无性行为(NSA)的个体)。
研究结果表明,FSFI-BC 的波斯语版本是乳腺癌幸存者性功能障碍筛查的合适工具。